In 2001 Trover Health System established the Trover Center for Clinical Studies to provide the 100+ Trover Health System physicians access to cutting edge medical technology. Our Goal is to bring the latest medical treatments to rural Western Kentucky and to provide our patients with early access to promising new medicine and medical technology.
Patients are offered the opportunity to participate in clinical trials for new medicines and the latest medical treatments. Patients qualifying for research studies may receive free physician care, study medication and other required test related to the trial. Research trials are supported by experienced Trover Health System physicians and Registered Nurse research coordinators trained in conducting research trials.
Current Trial Studies
Trover Research physicians and Mahr Cancer Center are currently conducting trial studies for the following medical conditions:
Type 2 Diabetic: Not currently on insulin (or in the past 60 days.) Males and/or females, 18-78 years old, and do not consider your diabetes well controlled. Be able to make 13 visits in 69 weeks to complete the study visits.
Type 2 Diabetes: Currently taking insulin but blood glucose is still too high (HbgA1c 7.5-11%). Male or females, 21 years of age or older. Study participation will be aprox. 7 months including 7 office visits. If you qualify, you will receive study-related care and study medication at no charge.
Type 2 Diabetes: Currently taking at least 2 oral diabetic medications but blood glucose is still too high and your physician has mentioned insulin as a possible option. Male or females, age 30-79. Study particpation can be from 6 months to 30 months according to how well your diabetes is controlled the first 6 months of the trial. If you qualify, you will receive office visits, medical evaluations and investigational medications related to the study at no charge.
Clinical Trial for Women with Irritable Bowel Syndrome (IBS): The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatment of diarrhea-predominant irritable bowel syndrome. The investigational drug is a natural product taken from a plant that grows in South America. The study medication will be administered orally twice a day. Subjects will be not able to remain on certain standard IBS medications (anti-diarrheals) while participating in the study. The total duration of the study is 18 weeks.
The study requires five study visits that include physical exams, ECG, blood draws, laboratory studies, and a colon procedure (such as a colonoscopy or flexible sigmoidoscopy if an appropriate procedure has not been performed in the last 5 years.) Participants will be asked to make entries into a touch-tone telephone diary on a daily basis.
Participants must meet all of the following criteria:
- Females at least 18 years of age
- Diagnosis of diarrhea predominant Irritable Bowel Syndrome
- Willingness to make daily calls on a touch-tone telephone
- Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not received one in the past 5 years.
- Willingness to take an approved method of birth control (if required)
Participants CANNOT meet any of the following criteria:
- Serious medical or surgical conditions
- Colon Cancer, Crohns Disease or Ulcerative Colitis
- Pregnant or breast feeding
For more information call:
Trover Center for Clinical Studies
270-825-6643 or 1-800-733-2312 (and ask for the Trover Center for Clinical Studies)
Site Address: 800 Hospital Drive, Madisonville, Ky 42431
To qualify for participation you must also meet the medical history, screening test and physical examination requirements that are required by each clinical trial. contact a study coordinator at Trover Center for Clinical Studies at 270-825-6678 or 270-825-6643 or toll free at 1-800-733-2312 and ask for the research department.
